IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Kiora Pharmaceuticals Inc

CUSIP: 49721T309 | 38 institutional holders

Quarters

Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2024

Rosalind Advisors, Inc.255,555
0.6% of portfolio›$935.3K
StyleTurnoverLocationFiled
Rosalind Advisors, Inc.
255,555$935.3K0.6%GrowthHighToronto, Australia2024-10-30